Retatrutide, a new dual agonist of the GLP-1 receptor and glucose-dependent insulinotropic polypeptide (GIP) receptor , is demonstrating promising results in early human assessments . Ongoing research https://bookmarksbay.com/story21422963/retatrutide-emerging-studies-and-potential-medical-applications